• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间歇性运动状态下因子 VIII 和因子 IX 的增强降解。

Augmented Degradation of Factors VIII and IX in the Intermittent Movement State.

机构信息

Thrombosis and Hemostasis Unit, Department of Hematology, Rambam Health Care Campus, Haifa P.O. Box 9602, Israel.

The Rappaport Faculty of Medicine, Technion, Haifa P.O. Box 9602, Israel.

出版信息

Int J Mol Sci. 2023 Jun 27;24(13):10731. doi: 10.3390/ijms241310731.

DOI:10.3390/ijms241310731
PMID:37445906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10341814/
Abstract

The most common clinical presentation of hemophilia A and hemophilia B is bleeding in large joints and striated muscles. It is unclear why bleeding has a predilection to affect joints and muscles. As muscles and joints are involved in intermittent movement, we explored whether this phenomenon could be associated with an impact on factor VIII and IX levels. Purified proteins and a mouse model were assessed using coagulation assays, Western blot analysis and immuno-staining. Movement caused an increase in thrombin activity and a decrease in factor VIII and factor IX activity. The decrease in factor VIII activity was more significant in the presence of thrombin and during movement. Under movement condition, sodium ions appeared to enhance the activity of thrombin that resulted in decreased factor VIII activity. Unlike factor VIII, the reduction in factor IX levels in the movement condition was thrombin-independent. High factor VIII levels were found to protect factor IX from degradation and vice versa. In mice that were in movement, factor VIII and IX levels decreased in the microcirculation of the muscle tissue compared with other tissues and to the muscle tissue at rest. Movement had no effect on von Willebrand factor levels. Movement induces reduction in factor VIII and IX levels. It enables an increase in the binding of sodium ions to thrombin leading to enhanced thrombin activity and augmented degradation of factor VIII. These data suggest a potential mechanism underlying the tendency of hemophilia patients to bleed in muscles and joints.

摘要

A 和 B 型血友病最常见的临床表现是大关节和横纹肌出血。目前尚不清楚为什么出血会偏爱影响关节和肌肉。由于肌肉和关节参与间歇性运动,我们探讨了这种现象是否与因子 VIII 和 IX 水平的影响有关。我们使用凝血测定法、Western blot 分析和免疫染色法评估了纯化蛋白和小鼠模型。运动导致凝血酶活性增加,因子 VIII 和因子 IX 活性降低。在存在凝血酶和运动时,因子 VIII 活性的降低更为显著。在运动条件下,钠离子似乎增强了凝血酶的活性,导致因子 VIII 活性降低。与因子 VIII 不同,运动条件下因子 IX 水平的降低与凝血酶无关。高因子 VIII 水平被发现可防止因子 IX 降解,反之亦然。与其他组织相比,在运动的小鼠中,肌肉组织的微血管中的因子 VIII 和 IX 水平下降,而在休息的肌肉组织中则下降。运动对血管性血友病因子水平没有影响。运动导致因子 VIII 和 IX 水平降低。它使钠离子与凝血酶的结合增加,导致凝血酶活性增强和因子 VIII 降解增加。这些数据表明了血友病患者在肌肉和关节中出血的倾向的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/623dc7e1b5ea/ijms-24-10731-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/dc2ccdd2f2f9/ijms-24-10731-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/98d24b3be5e1/ijms-24-10731-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/9b27059028c0/ijms-24-10731-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/3247fb98e30e/ijms-24-10731-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/2e225d86ac04/ijms-24-10731-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/4c69aeaf262c/ijms-24-10731-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/566c4ba38704/ijms-24-10731-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/758b91a5d53d/ijms-24-10731-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/623dc7e1b5ea/ijms-24-10731-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/dc2ccdd2f2f9/ijms-24-10731-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/98d24b3be5e1/ijms-24-10731-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/9b27059028c0/ijms-24-10731-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/3247fb98e30e/ijms-24-10731-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/2e225d86ac04/ijms-24-10731-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/4c69aeaf262c/ijms-24-10731-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/566c4ba38704/ijms-24-10731-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/758b91a5d53d/ijms-24-10731-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f32e/10341814/623dc7e1b5ea/ijms-24-10731-g008.jpg

相似文献

1
Augmented Degradation of Factors VIII and IX in the Intermittent Movement State.间歇性运动状态下因子 VIII 和因子 IX 的增强降解。
Int J Mol Sci. 2023 Jun 27;24(13):10731. doi: 10.3390/ijms241310731.
2
Calcium Prevents Enhanced Degradation of Factor VIII in the Condition of Motion.钙可防止运动状态下因子 VIII 降解增强。
Biology (Basel). 2023 Oct 30;12(11):1388. doi: 10.3390/biology12111388.
3
Prediction of individual factor VIII or IX level for the correction of thrombin generation in haemophilic patients.预测血友病患者凝血酶生成的个体因子 VIII 或 IX 水平以进行校正。
Haemophilia. 2018 Nov;24(6):995-1001. doi: 10.1111/hae.13539. Epub 2018 Jun 29.
4
Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.血友病和血管性血友病:2. 管理。加拿大血友病诊所主任协会
CMAJ. 1995 Jul 15;153(2):147-57.
5
Potential role of recombinant factor VIIa as a hemostatic agent.重组凝血因子VIIa作为止血剂的潜在作用。
Clin Adv Hematol Oncol. 2003 Feb;1(2):112-9.
6
Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment.凝血酶处理因子VIII制剂及Ca2+解离的小活性片段的效果。
J Clin Invest. 1975 Sep;56(3):751-60. doi: 10.1172/JCI108146.
7
Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor.血友病作为凝血组织因子途径的缺陷:因子VIII和IX对连续流动反应器中因子X激活的影响。
Proc Natl Acad Sci U S A. 1990 Oct;87(19):7623-7. doi: 10.1073/pnas.87.19.7623.
8
An in vitro analysis of the combination of hemophilia A and factor V(LEIDEN).甲型血友病与因子V(莱顿)联合的体外分析。
Blood. 1997 Oct 15;90(8):3067-72.
9
Targeting TFPI for hemophilia treatment.以组织因子途径抑制物为靶点治疗血友病。
Thromb Res. 2016 May;141 Suppl 2(Suppl 2):S28-30. doi: 10.1016/S0049-3848(16)30359-0.
10
[A new therapy of hemophilia with ranitidine].[雷尼替丁治疗血友病的新疗法]
Zhonghua Nei Ke Za Zhi. 1990 Feb;29(2):85-7, 125.

引用本文的文献

1
Calcium Prevents Enhanced Degradation of Factor VIII in the Condition of Motion.钙可防止运动状态下因子 VIII 降解增强。
Biology (Basel). 2023 Oct 30;12(11):1388. doi: 10.3390/biology12111388.

本文引用的文献

1
Hemostatic Resuscitation in Children.儿童止血复苏
Transfus Med Rev. 2021 Oct;35(4):113-117. doi: 10.1016/j.tmrv.2021.06.008. Epub 2021 Aug 26.
2
Prehospital whole blood reduces early mortality in patients with hemorrhagic shock.院前输注全血可降低失血性休克患者的早期死亡率。
Transfusion. 2021 Jul;61 Suppl 1:S15-S21. doi: 10.1111/trf.16528.
3
Activated protein C has a regulatory role in factor VIII function.活化蛋白 C 在因子 VIII 功能中具有调节作用。
Blood. 2021 May 6;137(18):2532-2543. doi: 10.1182/blood.2020007562.
4
Coagulation factor VIII is vital for increasing global coagulation after physical exercise.凝血因子 VIII 对于增加运动后的全身凝血至关重要。
Haemophilia. 2019 Mar;25(2):e86-e93. doi: 10.1111/hae.13652. Epub 2019 Jan 21.
5
Trauma, Time, and Transfusions: A Longitudinal Analysis of Coagulation Markers in Severely Injured Trauma Patients Receiving Modified Whole Blood or Component Blood Products.创伤、时间与输血:对接受改良全血或成分血制品的严重创伤患者凝血标志物的纵向分析
Shock. 2015 Nov;44(5):417-25. doi: 10.1097/SHK.0000000000000449.
6
Treatment of haemophilia A and B and von Willebrand's disease: summary and conclusions of a systematic review as part of a Swedish health-technology assessment.A 及 B 型血友病和血管性血友病的治疗:作为瑞典卫生技术评估的一部分,系统评价的总结和结论。
Haemophilia. 2012 Mar;18(2):158-65. doi: 10.1111/j.1365-2516.2011.02723.x. Epub 2011 Dec 12.
7
Factor VIII structure and function.凝血因子VIII的结构与功能。
Int J Hematol. 2006 Feb;83(2):103-8. doi: 10.1532/IJH97.05113.
8
Molecular dissection of Na+ binding to thrombin.钠离子与凝血酶结合的分子解析
J Biol Chem. 2004 Jul 23;279(30):31842-53. doi: 10.1074/jbc.M401756200. Epub 2004 May 19.
9
Haemophilias A and B.血友病A和B。
Lancet. 2003 May 24;361(9371):1801-9. doi: 10.1016/S0140-6736(03)13405-8.
10
Crystal structure of the anticoagulant slow form of thrombin.凝血酶抗凝慢型的晶体结构
J Biol Chem. 2002 Oct 25;277(43):40177-80. doi: 10.1074/jbc.C200465200. Epub 2002 Aug 29.